Inside April 2014 Edition
| President's Message | SITC in Action |
SITC 2014 Updates | Society Updates |
Meeting Notices |
Dear Colleagues,
The Society for Immunotherapy of Cancer recognizes that accessibility is an essential component to driving the field of cancer immunotherapy forward and, therefore, seeks to expand its impact by working with like-minded organizations to expand educational efforts. Through these opportunities, scientists from around the globe are collaborating, communicating and ultimately spearheading key advances in the field of cancer immunotherapy.
This type of global activity is essential, as it is through these partnerships that SITC members provide cancer immunotherapy education to broad audiences around the world and increase excitement and advocacy within the field.
This past month, SITC was one of the cosponsors of ITOC-1 Immunotherapy of Cancer Conference in Munich, Germany. Next month SITC will host Cancer Immunology and Immunotherapy: From Basic Science to Clinical Application as guest society symposium at the 2014 AAI Annual Meeting. Then on May 30, SITC heads to the ASCO Annual Meeting for a program on Tumor Immunology 101: A Navigation Guide for the New Field of Immuno-Oncology.
I invite you to join SITC at these upcoming conferences and through our educational opportunities, research and live meetings.
Sincerely,
.jpg){kind=small}
Francesco M. Marincola, MD
SITC President
ITOC-1 Abstracts Available on JITC
In Munich, Germany, the ITOC-1 Immunotherapy of Cancer Conference, in which SITC was one of the co-sponsors, saw drug developers, clinicians, immunologists and scientists from around the world participate in the immunotherapy discussion.
Dr. Thomas Gajewski, SITC Past President and current SITC member, attended the meeting and said, "The inaugural ITOC conference was a huge success. The meeting was truly international, with a spectrum of countries represented in terms of speakers and attendees. The quality of the discussion was very high, and I was impressed by the number of European biotech companies participating. All of this came together to foster new interactions and the potential for important new collaborations."
The Journal for Immunotherapy of Cancer (JITC) has published a collection of selected abstracts from the ITOC-1 conference. To access these articles, please click here.
Attend SITC Guest Symposium at American Association of Immunologists (AAI) Meeting on May 5, 2014!
SITC returns for Immunology 2014TM to introduce the fundamentals of cancer immunotherapy and address how basic science advancements are being put to practice in the clinical setting. This symposium will discuss the transition of adoptive T-cell therapy from research to practice, take a closer look at the growing targets of the PD-L1/PD-1 axis in cancer immunotherapy, and explore new directions and combinations for anti-CTLA-4 mAb.
SITC Holds Tumor Immunology 101 Leading into ASCO on May 30, 2014
.png)
This CME-certified session, an Affiliate Program of the SITC ACI™ Series that is held prior to the 2014 ASCO Annual Meeting, will solidify knowledge in the promising field of immuno-oncology and provide the introductory and background information needed before attending other cancer immunotherapy programs.
As a society, SITC recognizes the need for immuno-oncology education at all levels and is excited to offer this program to clinical oncologists, early career individuals, allied health professionals, patient advocates, industry professionals and all others involved in the field.
SITC 29th Annual Meeting Call for Abstracts!
 |
SITC will offer a total of 20 Travel Awards to those who qualify and submit abstracts in conjunction with the 29th Annual Meeting. These awards give young investigators the opportunity to present posters and/or oral abstracts during the Annual Meeting as well as provide travel support and promotional opportunities for award recipients and their research. This includes publication of accepted abstracts in JITC. |
Exhibit Registration Open for Priority Booth Placement
From now until May 7, SITC is accepting exhibit booth applications for Deluxe and Premier exhibitors for the 29th Annual Meeting in National Harbor, MD taking place November 7-8, 2014. Please note that this priority booth reservation is open for a limited time. On May 8, booth registration will be open to all exhibit tiers. For exhibit details, pricing, and conference statistics, click here to access the 2014 Exhibitor Prospectus.
SITC Announces Two $1,000 Awards for Best Papers Published in JITC
SITC is sponsoring two new $1,000 USD awards for manuscripts published in JITC! The JITC Best Clinical Application Paper and the JITC Best Basic Science Paper Awards will celebrate excellence in scientific research and be awarded to researchers demonstrating leadership in the field as well as innovation and high-quality execution and discussion in their manuscripts. Along with their $1,000 prize, award winners will also be featured in Society publications and to SITC’s constituency group of more than 5,000 experts in the field.
To be eligible, papers must be published in JITC by August 19, 2014. For more information regarding the SITC Best Paper Awards please visit www.sitcancer.org/journal or contact info@sitcancer.org.
SITC Invites You to Rock at the Chicago House of Blues on June 1, 2014
For a suggested minimum donation of $25, you can let loose after a day of education at ASCO in one of the Windy City’s premier music venues. Live entertainment will be provided by SITC’s very own house band, The CheckPoints. As the highlight of the night, SITC will announce the winner of the first SITC-EMD Serono Cancer Immunotherapy Clinical Fellowship. To view the official page, click here.
Visit the SITC Job Board to Search the Hottest Immunotherapy-related Job Openings
Are you looking to apply for a job in the immunotherapy field? Is your institution looking to fill an opening? Visit the SITC Job Board! Our page hosts a variety of openings from top cancer research institutions in the field. To see a full list of openings or to learn more about how we can promote an opening, please click here.
Register today for “Cancer Immunology and Immunotherapy: Delivering the Promise”
Date: October 9-10, 2014
Location: Masur Auditorium, Blg 10, NIH, Bethesda, MD
Conference website: http://ncifrederick.cancer.gov/events/CancerImmunology/default.asp
The Center for Cancer Research at the National Cancer Institute is hosting a two-day national symposium entitled " Cancer Immunology and Immunotherapy: Delivering the Promise." The program includes recent advances in the field and should be an exciting forum for discussion and debate on the current understanding on the immunotherapy of cancer.
Sessions and speakers include:
- Adoptive Cell Therapies
Steven Rosenberg, Nicholas Restifo, Patrick Hwu, Ton Schumacher, Philip Greenberg, Dirk Busch - Genetic Engineering of the Immune System
Malcolm Brenner, James Kochenderfer, Michel Sadelain, Carl June, Stanley Riddell, Crystal Mackall, Laurence Cooper - Checkpoint Modulators
Suzanne Topalian, Jedd Wolchok, Stephen Hodi, James Allison - Other Approaches to Cancer Immunotherapy
Dan Fowler, Jeffrey Miller, Ronald Levy, Thomas Waldmann, Jeffrey Schlom, James Yang
Registration is free, but seating is limited so be sure to register early! Online registration can be found at: http://ncifrederick.cancer.gov/events/CancerImmunology/register.asp
Please mark October 9-10, 2014, on your calendar for this exciting event, and forward this email to colleagues. For conference-related questions, please contact Diana Linnekin at dlinnekin@mail.ncifcrf.gov
Final Program for the Immunotherapy and Immunoscore Meeting is Now Online
Date: July 3-4, 2014
Location: Paris, France
Please click here to view the final program for the SITC-sponsored "Natural and therapy-induced anticancer immunosurveillance: the Immunoscore" program. Registration is open, and the meeting is free of charge. To view the official registration, please click here.
For more information on the SITC Immunoscore Project, please click here.
